Age over 55 Years at Diagnosis Increases Risk of Second Malignancies after Auto-Transplantation for Hodgkin's Lymphoma Patients
暂无分享,去创建一个
E. Shpall | Y. Nieto | U. Popat | M. Qazilbash | A. Alousi | R. Champlin | M. Fanale | P. Anderlini | S. Pingali | C. Hosing | P. Kebriaei | I. Khouri | R. Saliba
[1] J. Raemaekers,et al. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma. , 2015, The New England journal of medicine.
[2] E. Riedel,et al. Late morbidity and mortality in patients with Hodgkin's lymphoma treated during adulthood. , 2015, Journal of the National Cancer Institute.
[3] S. Gabriel,et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.
[4] R. Greil,et al. ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trials. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Bingshu E. Chen,et al. ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma. , 2012, The New England journal of medicine.
[6] H. Tilly,et al. Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT). , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] A. Rossi,et al. Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] J. Wingard,et al. Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. , 2010, Blood.
[9] V. Diehl,et al. Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] U. Popat,et al. Age at diagnosis does not adversely affect outcome in patients with Hodgkin's Disease (HD) after autologous transplantation. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] A. Horwich,et al. Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] U. Popat,et al. High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[13] H. Brenner,et al. Ongoing improvement in long-term survival of patients with Hodgkin disease at all ages and recent catch-up of older patients. , 2008, Blood.
[14] R. Hoover,et al. New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000. , 2006 .
[15] V. Diehl,et al. Hodgkin's lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin's Study Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] J. Connors,et al. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] J. Garcia-conde,et al. Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[18] V. Diehl,et al. Part II: Hodgkin's lymphoma--diagnosis and treatment. , 2004, The Lancet. Oncology.
[19] D. Hogge,et al. Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis , 2003, Bone Marrow Transplantation.
[20] J. Vose,et al. Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study. , 2003, Blood.
[21] J. Armitage,et al. The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] Dirk Hasenclever,et al. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial , 2002, The Lancet.
[23] A. Levis,et al. Hodgkin's disease in the elderly: current status and future directions. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[24] G. Salles,et al. Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] V. Diehl,et al. Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group. , 2000, Blood.
[26] Olker,et al. A PROGNOSTIC SCORE FOR ADVANCED HODGKIN ’ S DISEASE , 2000 .
[27] N. Schmitz,et al. Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT , 1999, British journal of haematology.
[28] J. Armitage,et al. Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] B. Coiffier,et al. Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study. Société Francaise de Greffe de Moelle. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] M. Abdelguerfi,et al. Introduction 1.2 Parallel Database Systems 1.2.1 Computation Model 2 1.2 Parallel Database Systems Introduction Select * from Employee, Department Where (employee.dept_no @bullet Department.dept_no) and (employee.position = "manager") (a) Sql Request 1.2.2 Engineering Model , 2022 .
[31] J. Armitage,et al. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. , 1998, The New England journal of medicine.
[32] C. Gisselbrecht,et al. Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease. , 1998, Blood.
[33] S. Horning,et al. Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease. , 1997, Blood.
[34] L. Robison,et al. Malignant neoplasms following bone marrow transplantation. , 1996, Blood.
[35] D. Neuberg,et al. Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] D. Winfield,et al. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial , 1993, The Lancet.
[37] R. Chopra,et al. The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients. , 1993, Blood.
[38] J. Gribben,et al. Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantation. , 1989, Blood.
[39] P. Mazza,et al. High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] C. Percy,et al. Cancer incidence and mortality in the United States, 1973-77. , 1981, National Cancer Institute monograph.
[41] J. Holý,et al. [Epidemiology of Hodgkin's disease]. , 1977, Ceskoslovenska pediatrie.
[42] John McGrath,et al. Hodgkin’s Disease , 1933, JAMA.